Literature DB >> 25774867

Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

Man Po Lee1, Jialun Zhou, Liesl Messerschmidt, Miwako Honda, Rossana Ditangco, Thira Sirisanthana, Nagalingeswaran Kumarasamy, Praphan Phanuphak, Yi-Ming Arthur Chen, Fujie Zhang, Vonthanak Saphonn, Sasisopin Kiertiburanakul, Christopher K C Lee, Sanjay Pujari, Jun Yong Choi, Adeeba Kamarulzaman, Evy Yunihastuti, Tuti Parwati Merati, Poh-Lian Lim, Patrick C K Li.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25774867      PMCID： PMC4410445          DOI： 10.1089/apc.2014.0232

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  10 in total

1.  Some patient-related factors associated with late access to ART in China's free ART program.

Authors:  Yi Wen; Decai Zhao; Zhihui Dou; Ye Ma; Yan Zhao; Lin Lu; Wei Liu; Hao Zhu; Fujie Zhang
Journal:  AIDS Care       Date:  2011-06-21

Review 2.  Sex differences in antiretroviral therapy-associated intolerance and adverse events.

Authors:  Rebecca Clark
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team.

Authors:  J S Currier; C Spino; J Grimes; C B Wofsy; D A Katzenstein; M D Hughes; S M Hammer; D J Cotton
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-01       Impact factor: 3.731

Review 4.  Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.

Authors:  Obiamiwe C Umeh; Judith S Currier
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-04       Impact factor: 4.481

5.  Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda.

Authors:  Arif Alibhai; Walter Kipp; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Stan Houston; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale
Journal:  Int J Womens Health       Date:  2010-08-09

6.  Gender and access to HIV testing and antiretroviral treatments in Thailand: why do women have more and earlier access?

Authors:  Sophie Le Coeur; Intira J Collins; Julie Pannetier; Eva Lelièvre
Journal:  Soc Sci Med       Date:  2009-07-01       Impact factor: 4.634

Review 7.  Gender differences in the treatment of HIV infection.

Authors:  Marco Floridia; Marina Giuliano; Lucia Palmisano; Stefano Vella
Journal:  Pharmacol Res       Date:  2008-07-30       Impact factor: 7.658

Review 8.  Sex differences in pharmacokinetics and pharmacodynamics.

Authors:  Monica Gandhi; Francesca Aweeka; Ruth M Greenblatt; Terrence F Blaschke
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

9.  The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.

Authors:  Morna Cornell; Landon Myer; Richard Kaplan; Linda-Gail Bekker; Robin Wood
Journal:  Trop Med Int Health       Date:  2009-04-27       Impact factor: 2.622

10.  The TREAT Asia HIV Observational Database: baseline and retrospective data.

Authors:  Jialun Zhou; N Kumarasamy; Rossana Ditangco; Adeeba Kamarulzaman; Christopher K C Lee; Patrick C K Li; Nicholas I Paton; Praphan Phanuphak; Sanjay Pujari; Asda Vibhagool; Wing-Wai Wong; Fujie Zhang; John Chuah; Kevin R Frost; David A Cooper; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.771
  10 in total
  6 in total

Review 1.  The Impact of Antiretroviral Therapy on Neurocognitive Outcomes Among People Living with HIV in Low- and Middle-Income Countries (LMICs): A Systematic Review.

Authors:  Henry Ukachukwu Michael; Sasha Naidoo; Kofi Boamah Mensah; Suvira Ramlall; Frasia Oosthuizen
Journal:  AIDS Behav       Date:  2021-02

2.  Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.

Authors:  Seema T Meloni; Charlotte A Chang; Geoffrey Eisen; Toyin Jolayemi; Bolanle Banigbe; Prosper I Okonkwo; Phyllis J Kanki
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

3.  Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).

Authors:  Michelle L Giles; Amit C Achhra; Alison G Abraham; Andreas D Haas; Michael John Gill; Man Po Lee; Marco Luque; Catherine McGowan; Morna Cornell; Paula Braitstein; Nathalie de Rekeneire; Renaud Becquet; Kara Wools-Kaloustian; Matthew Law
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

4.  All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.

Authors: 
Journal:  AIDS       Date:  2020-02-01       Impact factor: 4.632

5.  High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa.

Authors:  Kogieleum Naidoo; Razia Hassan-Moosa; Nonhlanhla Yende-Zuma; Dhineshree Govender; Nesri Padayatchi; Halima Dawood; Rochelle Nicola Adams; Aveshen Govender; Tilagavathy Chinappa; Salim Abdool-Karim; Quarraisha Abdool-Karim
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

6.  Ten-year survival with analysis of gender difference, risk factors, and causes of death during 13 years of public antiretroviral therapy in rural Kenya.

Authors:  Luqman Mushila Hodgkinson; Roselyne Asiko Abwalaba; John Arudo; Michele Barry
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.